Expired contract

Research mDNA

Details

Value
£93,526.72
Duration
11 months
Topic
Research services
Published
21 November 2023

Tender description

Feasibility study investigating circulating peripheral mitochondrial DNA as a potential non-invasive biomarker for diagnosis and surveillance of high-risk cutaneous melanoma

Timeline

  1. Completed: Award date6 March 2023
  2. Completed: Award published21 November 2023
    Current notice
  3. Completed: Contract expiry date31 January 2024

About the buyer

Norfolk and Norwich University Hospitals NHS Foundation Trust runs a teaching hospital for Norfolk and north Suffolk. The trust buys as an NHS trust with its own procurement team. Much collaborative buying runs through the Norfolk and Waveney Procurement Collaboration, a partnership of every NHS provider trust in the local Integrated Care System.

A forward pipeline of upcoming procurement opportunities is published and updated regularly.

Over the past 5 years, most of Norfolk and Norwich University Hospitals NHS Foundation Trust's contract awards have been in medical equipment and pharmaceuticals, health and social work and repair and maintenance.

Relevant CPV codes

  • 73110000 · Research services

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

39 similar open tenders

See more open tenders related to Research mDNA.

Explore all open tenders

Related topics

Topics related to Research mDNA, ranked by notice volume.

View all topics
TopicCountValue
  1. 5,906
    £235.5bn

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.